Economic incentives and mathematical models of disease

Environment and Development Economics

Volumn 12, Issue 5, 2007, Pages 707-732

  Klein, Eili ^a   Laxminarayan, Ramanan ^a   Smith, David L ^b   Gilligan, Christopher A ^c  

^a RESOURCES FOR THE FUTURE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34848871048     PISSN: 1355770X     EISSN: 14697998     Source Type: Journal    
DOI: 10.1017/S1355770X0700383X     Document Type: Article

References (138)

1. Anderson, R. and M. Hanson (2005), 'Potential public health impact of imperfect HIV type 1 vaccines', The Journal of Infectious Diseases 191: S85-S96.
2. Anderson, R.M. and R.M. May (1991), Infectious Diseases of Humans, Oxford: Oxford University Press.
3. Anderson, R.M., R.M. May, K. Joysey, D. Mollison, G.R. Conway, R. Cartwell, H.V. Thompson, and B. Dixon (1986),'The invasion, persistence and spread of infectious diseases within animal and plant communities [and discussion]', Philosophical Transactions of the Royal Society of London: Series B, Biological Sciences 314: 533-570.
4. Auld, M.C. (2003), 'Choices, beliefs, and infectious disease dynamics', Journal of Health Economics 22: 361-377.
5. Aylward, R.B., H.F. Hull, S.L. Cochi, R.W. Sutter, J.M. Olive, and B. Melgaard (2000), 'Disease eradication as a public health strategy: A case study of poliomyelitis eradication', Bulletin of the World Health Organization 78: 285-297.
6. Barrett, S. (2003), 'Global disease eradication', Journal of the European Economic Association 1: 591-600.
7. Barrett, S. (2004), 'Eradication versus control: The economics of global infectious disease policies', Bulletin of the World Health Organization 82: 683-688.
8. Bart, K.J., J. Foulds, and P. Patriarca (1996), 'Global eradication of poliomyelitis: Benefit-cost analysis', Bulletin of the World Health Organization 74: 35-45.
9. Bartlett, M. (1956), 'Deterministic and stochastic models for recurrent epidemics', in J. Neyman (ed.), Proceedings of the Third Berkley Symposium on Mathematical Statistics and Probability, Berkley: University of California Press, pp. 81-109.
10. Bartlett, M. (1957), 'Measles periodicity and community size', Journal of the Royal Statistical Society, Series A (General) 120 48-70.
11. Bauch, C.T. and D.J.D. Earn (2004),'Vaccination and the theory of games', Proceedings of the National Academy of Sciences 101: 13391-13394.
12. Bauch, C.T., A.P. Galvani, and D.J.D. Earn (2003),'Group interest versus self-interest in smallpox vaccination policy', Proceedings of the National Academy of Sciences 100: 10564-10567.
13. Bergstrom, C.T., M. Lo, and M. Lipsitch (2004), 'Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals', Proceedings of the National Academy of Sciences 101: 13285-13290.
14. Block, S.L. (2004),'Role of influenza vaccine for healthy children in the US', Pediatric Drugs 6: 199-209.
15. Blower, S. and D. Bernoulli (2004), 'An attempt at a new analysis of the mortality caused by smallpox and of the advantages of inoculation to prevent it: 1766', Reviews in Medical Virology 14: 275-288.
16. Blower, S.M. and A.R. McLean (1991), 'Mixing ecology and epidemiology', Proceedings of the Royal Society of London: Series B, Biological Sciences 245: 187-192.
17. Blower, S.M. and A.R. McLean (1994), 'Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco', Science 265: 1451-1454.
18. Blower, S.M., H.B. Gershengorn, and R.M. Grant (2000),'A tale of two futures: HIV and antiretroviral therapy in San Francisco', Science 287: 650-654.
19. Blower, S., K. Koelle, and J. Mills (2002), 'Health policy modeling: epidemic control, HIV vaccines, and risky behavior', in E.H. Kaplan and Brookmeyer, R. (eds), Quantitative Evaluation of HIV Prevention Programs, New Haven, CT: Yale University Press, pp. 260-289.
20. Blower, S., L. Ma, P. Farmer, and S. Koenig (2003a), 'Predicting the impact of antiretrovirals in resource-poor settings: Preventing HIV infections whilst controlling drug resistance', Current drug targets. Infectious disorders 3: 345-353.
21. Blower, S., E.J. Schwartz, and J. Mills (2003b), 'Forecasting the future of HIV epidemics: The impact of antiretroviral therapies and imperfect vaccines', AIDS Reviews 5: 113-125.
22. Blythe, S.P., K.L. Cooke, and C. Castillo-Chavez (1991), 'Autonomous risk-behavior change, and non-linear incidence rate, in models of sexually transmitted diseases', Biometrics Unit Technical Report B-1048-M.
23. Bogard, E. and K.M. Kuntz (2002),'The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: A dynamic model', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 29: 132-141.
24. Bonhoeffer, S., M. Lipsitch, and B.R. Levin (1997), 'Evaluating treatment protocols to prevent antibiotic resistance', Proceedings of the National Academy of Sciences 94: 12106-12111.
25. Boni, M.F. and M.W. Feldman (2005), 'Evolution of antibiotic resistance by human and bacterial niche construction', Evolution 59: 477-491.
26. Brauer, F., S.P. Blythe, and C. Castillo-Chavez (1992), 'Demographic recruitment in sexually transmitted diseases', Biometrics Unit Technical Report BU-1154-M.
27. Boyce, J.M. and D. Pittet (2002), 'Guideline for hand hygiene in health-care settings', American Journal of Infection Control 30 1-46.
28. Cairncross, S., E.I. Braide, and S.Z. Bugri (1996), 'Community participation in the eradication of guinea worm disease', Acta Tropica 61: 121-136.
29. Carlsson-Granér, U. and P.H. Thrall (2002), 'The spatial distribution of plant populations, disease dynamics and evolution of resistance', Oikos 97: 97-110.
30. Carmeli, Y., G. Eliopoulos, E. Mozaffari, and M. Samore (2002),'Health and economic outcomes of vancomycin-resistant enterococci', Archives of Internal Medicine 162: 2223-2228.
31. CIA (2000), 'The global infectious disease threat and its implications for the United States', US Central Intelligence Agency. [online] available: http://www.dni.gov/nic/PDF_GIF_otherprod/ infectiousdisease/infectiousdiseases.pdf. Accessed: February 14, 2007.
32. Chambers, H.F. (2001), 'The changing epidemiology of staphylococcus aureus?', Emerging Infectious Diseases 7: 178-182.
33. Cline, B.L. and B.S. Hewlett (1996),'Community-based approach to schistosomiasis control', Acta Tropica 61: 107-119.
34. Cosgrove, S.E., G. Sakoulas, E.N. Perencevich, M.J. Schwaber, A.W. Karchmer, and Y. Carmeli (2003), 'Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis', Clinical Infectious Diseases 36: 53-59.
35. Cosgrove, S.E., Y. Qi, K.S. Kaye, S. Harbarth, A.W. Karchmer, and Y. Carmeli (2005), 'The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges', Infection Control and Hospital Epidemiology 26: 166-174.
36. Croxson, B., P. Allen, J.A. Roberts, K. Archibald, S. Crawshaw, and L. Taylor (2003), 'The funding and organization of infection control in NHS hospital trusts: A study of infection control professionals views', Health Services Management Research 16: 71-84.
37. Del Valle, S., H. Hethcote, J.M. Hyman, and C. Castillo-Chavez (2005), 'Effects of behavioral changes in a smallpox attack model', Mathematical Biosciences 195: 228-251.
38. Dieckmann, U. (2002), 'Adaptive dynamics of pathogen-host interactions', in U. Dieckmann, J.A.J. Metz, M.W Sabelis and K. Sigmund (eds.), Adaptive Dynamics of Infectious Diseases: In pursuit of Virulence Management, Cambridge: Cambridge University Press.
39. Diamond, B. and N. York (2005), 'Global polio campaign doomed to fail, experts warn', Nature Medicine 11: 1260.
40. Dow, WH., T.J. Philipson, and X. Sala-i-Martin (1999),'Longevity complementarities under competing risks', The American Economic Review 89: 1358-1371.
41. Dybiec, B., A. Kleczkowski, and C.A. Gilligan (2004), 'Controlling disease spread on networks with incomplete knowledge', Physical Review: E, Statistical, Nonlinear and Soft Matter Physics 70: 066145.
42. Engemann, J.J., Y. Carmeli, S.E. Cosgrove, V.G. Fowler, M.Z. Bronstein, S.L. Trivette, J.P. Briggs, D.J. Sexton, and K.S. Kaye (2003), 'Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection', Clinical Infectious Diseases 36: 592-598.
43. Espinoza-Gómez, F., C.M. Hernández-Suárez, and R. Coll-Cárdenas (2002), 'Educational campaign versus malathion spraying for the control of Aedes aegypti in Colima, Mexico', Journal of Epidemiology and Community Health 56: 148-152.
44. Ferguson, N.M., C.A. Donnelly, and R.M. Anderson (2001), 'Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain', Nature 413: 542-548.
45. Ferguson, N.M., M.J. Keeling, W. John Edmunds, R. Gani, B.T. Grenfell, R.M. Anderson, and S. Leach (2003), 'Planning for smallpox outbreaks', Nature 425: 681-685.
46. Forster, G.A. and C.A. Gilligan (2007),'Optimizing the control of disease infestations at the landscape scale', Proceedings of the National Academy of Science 104: 4984-4989.
47. Freudenberg, N. (2001),'Jails, prisons, and the health of urban populations: A review of the impact of the correctional system on community health', Journal of Urban Health 78: 214-235.
48. Geoffard, P.Y. and T. Philipson (1996), 'Rational epidemics and their public control', International Economic Review 37: 603-624.
49. Geoffard, P.Y. and T. Philipson (1997), 'Disease eradication: Private versus public vaccination', American Economic Review 87: 222-230.
50. Gersovitz, M. and J.S. Hammer (2003), 'Infectious diseases, public policy, and the marriage of economics and epidemiology', World Bank Research Observer 18: 129-157.
51. Ghebreyesus, T.A., T. Alemayehu, A. Bosman, K.H. Witten, and A. Teklehaimanot (1996), 'Community participation in malaria control in Tigray region Ethiopia', Acta Tropica 61: 145-156.
52. Gibson, G.J., C.A. Gilligan, and A. Kleczkowski (1999), 'Predicting variability in biological control of a plant-pathogen system using stochastic models', Proceedings of the Royal Society of London. Series B, Biological Sciences 266: 1743-1753.
53. Gilligan, C.A. (2002), 'An epidemiological framework for disease management', Advances in Botanical Research 38: 1-64.
54. Glaser, J.B. and R.B. Greifinger (1993), 'Correctional health care: A public health opportunity', Annals of Internal Medicine 118: 139-145.
55. Goldman, S. and J. Lightwood (2002), 'Cost optimization in the SIS model of infectious disease with treatment', Topics in Economic Analysis and Policy 2: 1007-1007.
56. Gould, I.M. (2006), 'Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control', International Journal of Antimicrobial Agents 28: 379-384.
57. Graves, N. (2001), 'The cost of hospital acquired infections', in A. Netten, T. Rees, and G. Harrison (eds.), Unit Costs of Health and Social Care 2001, Canterbury: Personal Social Services Research Unit.
58. Graves, N. (2004), 'Economics and preventing hospital-acquired infection', Emerging Infectious Diseases 10: 561-566.
59. Gray, R.H., X. Li, M.J. Wawer, S.J. Gange, D. Serwadda, N.K. Sewankambo, R. Moore, F. Wabwire-Mangen, T. Lutalo, and T.C. Quinn (2003), 'Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda', AIDS 17: 1941-1951.
60. Grenfell, B.T., O.N. Bjornstad, and B.F. Finkenstadt (2002), 'Dynamics of measles epidemics: Scaling noise, determinism, and predictability with the TSIR model', Ecological Monographs 72: 185-232.
61. Grenfell, B.T. and A.P. Dobson (eds.) (1995), Ecology of Infectious Diseases in Natural Populations, Cambridge: Cambridge University Press.
62. Gubbins, S. and C.A. Gilligan (1997a), 'Biological control in a disturbed environment', Philosophical Transactions of the Royal Society B: Biological Sciences 352: 1935-1949.
63. Gubbins, S. and C.A. Gilligan (1997b), 'A test of heterogeneous mixing as a mechanism for ecological persistence in a disturbed environment', Proceedings of the Royal Society of London. Series B, Biological Sciences 264: 227-232.
64. Gubler, D.J. and G.G. Clark (1996), 'Community involvement in the control of Aedes aegypti', Acta Tropica 61: 169-179.
65. Hadeler, K.P. and C. Castillo-Chavez (1995), 'A core group model for disease transmission', Mathematical Biosciences 128: 41-55.
66. Hamer, W.H. (1906), 'The Milroy Lectures on epidemic disease in England - the evidence of variability and of persistency of type', The Lancet 167: 733-739.
67. Henderson, D.A. (1999), 'Lessons from the eradication campaigns', Vaccine 17: S53-55.
68. Hethcote, H.W. (2000), 'The mathematics of infectious diseases', SIAM Review 42: 599-653.
69. Hethcote, H.W. and J.A. Yorke (1984), 'Gonorrhea transmission dynamics and control', Lecture Notes in Biomathematics 56.
70. Hethcote, H.W., J.W. Van Ark, and J.M. Karon (1991), 'A simulation model of AIDS in San Francisco: II. Simulations, therapy, and sensitivity analysis', Mathematical Biosciences 106: 223-247.
71. Hyman, J.M. and J. Li (1997), 'Behavior changes in SIS STD models with selective mixing', SIAM Journal on Applied Mathematics 57: 1082-1094.
72. Keeling, M. (2005), 'The implications of network structure for epidemic dynamics', Theoretical Population Biology 67: 1-8.
73. Keeling, M.J. and C.A. Gilligan (2000), 'Metapopulation dynamics of bubonic plague', Nature 407: 903-906.
74. Keeling, M.J., M.E.J. Woolhouse, D.J. Shaw, L. Matthews, M. Chase-Topping, D.T. Haydon, S.J. Cornell, J. Kappey, J. Wilesmith, and B.T. Grenfell (2001), 'Dynamics of the 2001 UK Foot and Mouth Epidemic: Stochastic Dispersal in a Heterogeneous Landscape', Science 294 813-817.
75. Keeling, M.J., O.N. Bjørnstad, and B.T. Grenfell (2004), 'Metapopulation dynamics of infectious disease', in I. Hanski and O.E. Gaggiotti (eds.), Ecology, Genetics and Evolution of Metapopulations Amsterdam: Elsevier.
76. Kermack, W.O. and A.G. McKendrick (1927), 'A contribution to the mathematical theory of epidemics', Proceedings of the Royal Society of London. Series A, Mathematical, Physical and Engineering Sciences 115: 700-721.
77. Kleczkowski, A., C.A. Gilligan, and D.J. Bailey (1997), 'Scaling and spatial dynamics in plant-pathogen systems: From individuals to populations', Proceedings of the Royal Society of London. Series B, Biological Sciences 264: 979-984.
78. Klovdahl, A.S., J.J. Potterat, D.E. Woodhouse, J.B. Muth, S.Q. Muth, and W.W. Darrow (1994), 'Social networks and infectious disease: The Colorado Springs study', Social Science & Medicine 38: 79-88.
79. Koopman, J.S., C. Simon, J. Jacquez, J. Joseph, L. Sattenspiel, and T. Park (1988), 'Sexual partner selectiveness effects on homosexual HIV transmission dynamics', Journal of Acquired Immune Deficiency Syndromes 1: 486-504.
80. Koopman, J.S., I.M. Longini Jr, J.A. Jacquez, C.P. Simon, D.G. Ostrow, W.R. Martin, and D.M. Woodcock (1991), 'Assessing risk factors for transmission of infection' American Journal of Epidemiology 133 1199-1209.
81. Kremer, M. (1996), 'Integrating behavioral choice into epidemiological models of AIDS', The Quarterly Journal of Economics 111: 549-573.
82. Kretzschmar, M., Y.T.H.P. van Duynhoven, and A.J. Severijnen (1996), 'Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations', American Journal of Epidemiology 144: 306-317.
83. Laxminarayan, R. (2004), 'Act now or later? Economics of malaria resistance', The American Journal of Tropical Medicine and Hygiene 71: 187-195.
84. Laxminarayan, R. and G.M. Brown (2001), 'Economics of antibiotic resistance: A theory of optimal use', Journal of Environmental Economics and Management 42: 183-206.
85. Laxminarayan, R. and D.L. Smith (2006), 'Ecology and economics of cycling antibiotics: Insights from mathematical modeling', in C. Cuevas (ed.), Multiple Drug Resistant Bacteria, Norwich: Horizon Scientific Press.
86. Laxminarayan, R. and M.L. Weitzman (2002), 'On the implications of endogenous resistance to medications', Journal of Health Economics 21: 709-18.
87. Laxminarayan, R., M. Over, and D.L. Smith (2005), 'Will a global subsidy of artemisinin-based combination treatment (ACT) for malaria delay the emergence of resistance and save lives?', Washington, DC: The World Bank.
88. Laxminarayan, R., A.J. Mills, J.G. Breman, A.R. Measham, G. Alleyne, M. Claeson, P. Jha, P. Musgrove, J. Chow, S. Shahid-Salles, and D.T. Jamison (2006a), 'Advancement of global health: Key messages from the Disease Control Priorities Project', The Lancet 367: 1193-1208.
89. Laxminarayan, R., I. Parry, D.L. Smith, and E. Klein (2006b), 'Should new antimalarial drugs be subsidized?', Discussion Paper, RFF-DP-06-43, Resources for the Future, Washington, DC.
90. Lazaro, A. (2002), 'Theoretical arguments for the discounting of health consequences: Where do we go from here?', Pharmacoeconomics 20 943-961.
91. Liu, W.M., S.A. Levin, and Y. Iwasa (1986), 'Influence of nonlinear incidence rates upon the behavior of SIRS epidemiological models', Journal of Mathematical Biology 23: 187-204.
92. Liu, W.M., H.W. Hethcote, and S.A. Levin (1987), 'Dynamical behavior of epidemiological models with nonlinear incidence rates', Journal of Mathematical Biology 25: 359-380.
93. Mangel, M. and B.D. Roitberg (1995), 'Behavioral ecology, epidemiology and population genetics: The undiscovered country', Lecture Notes in Biomathematics 100: 238-251.
94. Martone, W.J. and R.L. Nichols (2001), 'Recognition, prevention, surveillance, and management of surgical site infections: Introduction to the problem and symposium overview', Clinical Infectious Diseases 33: S67-S68.
95. May, S.R. (2000), 'Simple rules with complex dynamics', Science 287: 601-602.
96. McCombie, S.C. (1986), 'The cultural impact of the 'AIDS' test: The American experience', Social Science & Medicine 23: 455-459.
97. McHugh, C.G. and L.W. Riley (2004), 'Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections', Infection Control and Hospital Epidemiology 25: 425-430.
98. Miguel, E. and M. Kremer (2004), 'Worms: Identifying impacts on education and health in the presence of treatment externalities', Econometrica 72(1): 159-217.
99. Moore, C. and M.E.J. Newman (2000), 'Epidemics and percolation in small-world networks', Physical Review E 61: 5678-5682.
100. Murray, B.E. (2000), 'Vancomycin-resistant enterococcal infections', The New England Journal of Medicine 342: 710-721.
101. Park, A.W., S. Gubbins, and C.A. Gilligan (2001), 'Invasion and persistence of plant parasites in a spatially structured host population', Oikos 94: 162-174.
102. Payne, D. (1987), 'Spread of chloroquine resistance in Plasmodium falciparum', Parasitology Today 3: 241-246.
103. Peltzman, S. (1975), 'The effects of automobile safety regulation', The Journal of Political Economy 83: 677-726.
104. Peltzman, S (1987), 'The health effects of mandatory prescriptions', Journal of Law and Economics 30: 207-238.
105. Peltzman, S. (2001), 'Offsetting behavior and medical breakthroughs', George J. Stigler Center for the Study of the Economy and the State, University of Chicago, Chicago, IL.
106. Philipson, T.J. and R.A. Posner (1993), Private Choices and Public Health: The AIDS Epidemic in an Economic Perspective, Cambridge, MA: Harvard University Press.
107. Ramalingaswami, V. (2001), 'Psychosocial effects of the 1994 plague outbreak in Surat, India', Military Medicine 166: 29-30.
108. Riley, S., C. Fraser, C.A. Donnelly, A.C. Ghani, L.J. Abu-Raddad, A.J. Hedley, G.M. Leung, L.-M. Ho, T.-H. Lam, T.Q. Thach, P. Chau, K.-P. Chan, S.-V. Lo, P.-Y. Leung, T. Tsang, W. Ho, K.-H. Lee, E.M.C. Lau, N.M. Ferguson, and R.M. Anderson (2003), 'Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions', Science 300: 1961-1966.
109. Roberts, D., S. Manguin, and J. Mouchet (2000a), 'DDT house spraying and reemerging malaria', The Lancet 356: 330-332.
110. Roberts, L., L. Jorm, M. Patel, W. Smith, R.M. Douglas, and C. McGilchrist (2000b), 'Effect of infection control measures on the frequency of diarrheal episodes in child care: A randomized, controlled trial', Pediatrics 105: 743-746.
111. Ross, R. (1910), The Prevention of Malaria, London: Murray.
112. Rowthorn, R.E. and G.M. Brown (2003), 'Using antibiotoics when resistance is renewable', in R. Laxminarayan (ed.), Battling Resistance to Antibiotics and Pesticides: An Economic Approach, Washington, DC: Resources for the Future.
113. Rubin, R.J., C.A. Harrington, A. Poon, K. Dietrich, J.A. Greene, and A. Moiduddin (1999), 'The economic impact of Staphylococcus aureus infection in New York City hospitals', Emerging Infectious Diseases 5: 9-17.
114. Sethi, S.P. (1974), 'Quantitative guidelines for communicable disease control program: A complete synthesis', Biometrics 30: 681-691.
115. Severens, J.L. and R.J. Milne (2004), 'Discounting health outcomes in economic evaluation: The ongoing debate', Value in Health 7: 397-401.
116. Smith, D.L., S.A. Levin, and R. Laxminarayan (2005), 'Strategic interactions in multi-institutional epidemics of antibiotic resistance', Proceedings of the National Academy of Sciences 102: 3153-3158.
117. Smith, D.L., B.T. Lucey, L.A. Waller, J.E. Childs, and L.A. Real (2002), 'Predicting the spatial dynamics of rabies epidemics on heterogeneous landscapes', Proceedings of the National Academy of Sciences 99 3668-3672.
118. Smith, R. (2003), 'What does economics have to offer in the war against antimicrobial resistance?', in S. Knobler, S. Lemon, M. Najafi, and T. Burroughs (eds.), The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment Workshop Summary, Washington, DC: National Academies Press.
119. Smith, R.J. and S.M. Blower (2004), 'Could disease-modifying HIV vaccines cause population-level perversity?', The Lancet Infectious Diseases 4: 636-639.
120. Snow, J. (1855), On the Mode of Communication of Cholera, London: John Chuchill.
121. Snow, R.W., J.-F. Trape, and K. Marsh (2001), 'The past, present and future of childhood malaria mortality in Africa', Trends in Parasitology 17: 593-597.
122. Song, X., A. Srinivasan, D. Plaut, and T.M. Perl (2003), 'Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs', Infection Control and Hospital Epidemiology 24: 251-256.
123. Stigum, H., P. Magnus, and L.S. Bakketeig (1997), 'Effect of changing partnership formation rates on the spread of sexually transmitted diseases and human immunodeficiency virus', American Journal of Epidemiology 145: 644-652.
124. Stosor, V., L.R. Peterson, M. Postelnick, and G.A. Noskin (1998), ' Enterococcus faecium bacteremia: Does vancomycin resistance make a difference?', Archives of Internal Medicine 158: 522-527.
125. Stover, J., G.P. Garnett, S. Seitz, and S. Forsythe (2002), The Epidemiological Impact of an HIV/AIDS Vaccine in Developing Countries Washington, DC: World Bank.
126. Swinton, J., C.A. Gilligan, J. Harwood, and A.J. Hall (1999), 'Scaling of phocine distemper virus transmission with harbour seal community size', Ecologie 30:231-240.
127. Tanaka, M.M., J. Kumm, and M.W. Feldman (2002), 'Coevolution of pathogens and cultural practices: A new look at behavioral heterogeneity in epidemics', Theoretical Population Biology 62:111-119.
128. Toole, M.J. and R.J. Waldman (1997), 'The public health aspects of complex emergencies and refugee situations', Annual Review of Public Health 18: 283-312.
129. Torgerson, D.J. and J. Raftery (1999), 'Economics notes: Discounting', British Medical Journal 319: 914-915.
130. Trape, J. (2001), 'The public health impact of chloroquine resistance in Africa', The American Journal of Tropical Medicine and Hygiene 64: 12-17.
131. US Congress, Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education and Related Agencies (1998), 'Testimony on Eradication of Polio and Control or Elimination of Measles by David Satcher MD, PhD, Assistant Secretary for Health and Surgeon General of the United States US Department of Health and Human Services, 23 September 1998', available from: http://www.hhs.gov/asl/testify/ t980923a.html. Accessed: 4 February 2007.
132. Velasco-Hernandez, J.X. and Y. Hsieh (1994), 'Modelling the effect of treatment and behavioral change in HIV transmission dynamics', Journal of Mathematical Biology 32: 233-249.
133. Viscusi, W.K. (1995), 'Discounting health effects for medical decisions', in Sloan, F. (ed.), Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies, Cambridge: Cambridge University Press, pp. 125-147.
134. Wallace, R. (1991), 'Traveling waves of HIV infection on a low dimensional "sociogeographic" network', Social Science and Medicine 32: 847-852.
135. Walker, L., H. LeVine, and M. Jucker (2006), 'Koch's postulates and infectious proteins', Acta Neuropathologica 112: 1-4.
136. Wenger, N., L. Linn, M. Epstein, and M. Shapiro (1991), 'Reduction of high-risk sexual behavior among heterosexuals undergoing HIV antibody testing: A randomized clinical trial', American Journal of Public Health 81: 1580-1585.
137. WHO (2001), 'Global strategy for the containment of antimicrobial resistance', WHO/CDS/CSR/DRS/2001/2/EN, Geneva: World Health Organization.
138. Wootton, J.C., X. Feng, M.T. Ferdig, R.A. Cooper, J. Mu, D.I. Baruch, A.J. Magill, and X.Z. Su (2002), 'Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum', Nature 418: 320-323.